Skip to main navigation Skip to search Skip to main content

The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up

  • Michel Komajda*
  • , Mathieu Kerneis
  • , Luigi Tavazzi
  • , Serban Balanescu
  • , Francesco Cosentino
  • , Alberto Cremonesi
  • , Roberto Ferrari
  • , Serge Kownator
  • , Hanna Szwed
  • , Iveta Mintale
  • , Zoran Olivari
  • , Harald Rittger
  • , Evgeny V. Shlyakhto
  • , Rimvydas Slapikas
  • , Philippe Gabriel Steg
  • , Marco Valgimigli
  • , Eric Van Belle
  • , Konstantinos Tsioufis
  • , Wojciech Majda
  • , Cécile Laroche
  • Aldo P. Maggioni
*Corresponding author for this work
  • Hôpital Saint-Joseph
  • Maria Cecilia Hospital
  • Monza Hospital Centru Cardiovascular
  • Karolinska Institutet
  • Centre Cardiologique et Vasculaire
  • Institute of Cardiology
  • Paula Stradina Clinical University Hospital
  • Ca’ Foncello
  • Medizinische Klinik I
  • Almazov Federal Medical Research Centre
  • Hospital of the Lithuanian Health Science University
  • Université Paris Cité
  • Erasmus University Rotterdam
  • University Hospital
  • National and Kapodistrian University of Athens
  • European Society of Cardiology
  • Associazione Nazionale Medici Cardiologi Ospedalieri

Research output: Contribution to journal › Article › peer-review

13 Citations (Scopus)

Abstract

Aim: Chronic ischaemic cardiovascular disease (CICD) remains a leading cause of morbidity and mortality worldwide. The CICD Pilot Registry enrolled 2420 patients across 10 European Society of Cardiology countries prospectively to describe characteristics, management strategies and clinical outcomes in this setting. We report here the six-month outcomes. Methods and results: From the overall population, 2203 patients were analysed at six months. Fifty-eight patients (2.6%) died after inclusion; 522 patients (23.7%) experienced all-cause hospitalisation or death. The rate of prescription of angiotensin-converting enzyme inhibitors, beta-blockers and aspirin was mildly decreased at six months (all P < 0.02). Patients who experienced all-cause hospitalisation or death were older, more often had a history of non-ST-segment elevation myocardial infarction, of chronic kidney disease, peripheral revascularisation and/or chronic obstructive pulmonary disease than those without events. Independent predictors of all-cause mortality/hospitalisation were age (hazard ratio (HR) 1.17, 95% confidence interval (CI) 1.07–1.27) per 10 years, and a history of previous peripheral revascularisation (HR 1.45, 95% CI 1.03–2.03), chronic kidney disease (HR 1.31, 95% CI 1.0–1.68) or chronic obstructive pulmonary disease (HR 1.42, 95% CI 1.06–1.91, all P < 0.05). We observed a higher rate of events in eastern, western and northern countries compared to southern countries and in cohort 1. Conclusion: In this contemporary European registry of CICD patients, the rate of severe clinical outcomes at six months was high and was influenced by age, heart rate and comorbidities. The medical management of this condition remains suboptimal, emphasising the need for larger registries with long-term follow-up. Ad-hoc programmes aimed at implementing guidelines adherence and follow-up procedures are necessary, in order to improve quality of care and patient outcomes.

Original languageEnglish
Pages (from-to)377-387
Number of pages11
JournalEuropean Journal of Preventive Cardiology
Volume25
Issue number4
DOIs
Publication statusPublished - 1 Mar 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Registries
  • ischaemic cardiovascular disease
  • outcomes
  • stable angina

Fingerprint

Dive into the research topics of 'The chronic ischaemic cardiovascular disease ESC Pilot Registry: Results of the six-month follow-up'. Together they form a unique fingerprint.

Cite this